Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/81438
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Post-transplant lymphoproliferative disorder: No relationship to recombinant human growth hormone use in Australian and New Zealand pediatric kidney transplant recipients
Author: Longmore, D.
Conwell, L.
Burke, J.
McDonald, S.
McTaggart, S.
Citation: Pediatric Transplantation, 2013; 17(8):731-736
Publisher: Wiley-Blackwell Publishing, Inc
Issue Date: 2013
ISSN: 1397-3142
1399-3046
Statement of
Responsibility: 
Danielle K. Longmore, Louise S. Conwell, John R. Burke, Stephen P. McDonald, and Steven J. McTaggart
Abstract: PTLD is a potentially life-limiting complication of pediatric transplantation. Previous registry-based studies in renal transplantation have suggested a link between rhGH use and PTLD. In this study, demographic and transplant data on those aged <18 yr and transplanted between 1991 and 2008 were collected from the ANZDATA Registry. Associations between gender, age at time of transplant, recipient CMV and EBV status, use of monoclonal antibody therapy, and use of rhGH were studied as potential predictors of PTLD. Among 650 transplants, there were 20 cases (3.1%) of PTLD, with half presenting within two yr post-transplant. Eight patients exposed to rhGH at any time developed PTLD, and this association was not statistically significant (RR = 1.5[0.6-3.4], p = 0.36). On multivariate analysis, there were no significant predictors for PTLD. In this study, previously identified potential risk factors were not identified as significant predictors for the development of PTLD. Although limited sample size may affect our ability to infer safety, this large retrospective cohort study does not suggest an increased risk of PTLD in pediatric kidney transplant recipients who received rhGH treatment.
Keywords: pediatrics; post-transplant lymphoproliferative disease; renal transplantation; Australian and New Zealand Dialysis and Transplant Registry; recombinant human growth hormone; kidney transplantation
Rights: © 2013 John Wiley & Sons A/S.
RMID: 0020132548
DOI: 10.1111/petr.12167
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.